Bevacizumab plus IFN-alpha-2a in First-line Treatment of Patients With Advanced or Metastatic Renal Cell Carcinoma: A Prospective German Non-interventional Study. [electronic resource]
Producer: 20190220Description: 875-882 p. digitalISSN:- 1791-7530
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Bevacizumab -- administration & dosage
- Carcinoma, Renal Cell -- drug therapy
- Disease Progression
- Disease-Free Survival
- Female
- Germany
- Humans
- Interferon-alpha -- administration & dosage
- Kidney Neoplasms -- drug therapy
- Male
- Middle Aged
- Neoplasm Metastasis
- Patient Safety
- Probability
- Prospective Studies
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Observational Study
There are no comments on this title.
Log in to your account to post a comment.